In what has become a something of a September tradition, Alcon invited members of the eye care press to their headquarters in Ft. Worth to update everyone on the most important developments at the company, and what you might see in the coming year.  I decided to take the trip to check out what was going on.


(this group of people is responsible for most of what you read about your chosen profession.. scary thought!)

Sergio Duplan, the President of Alcon North America, kicked off the presentations, and was followed by: the GM of Alcon US Vision Care, Sean Clark; the GM of Alcon US Surgical business, Jim Di Filippo; and a VP from their Medical Affairs division, Dr. Roee Lazebnik.

Here are my notes from the talks I thought ODwire folks would be most interested in. These are my totally biased opinions, mixed with some actual facts.

(Disclosure -- Alcon provided a buffet lunch for all attendees, and invited everyone who stayed in Ft. Worth after the event to dinner.  Other than that, the trip was on our own dime...)

In this InSight Studio interview from Optometry's Meeting 2019 in St. Louis, Dr. Ben Chudner sits down with us to discuss private equity in optometry. He hits on:

* What private equity is
* The differences between different private equity groups
* Where companies are looking to invest
* What makes a practice an attractive target for private equity
* Should your practice be acquired by private equity?

Leave any comments or questions for Dr. Chudner in this thread.

We'd like to invite you to an upcoming, free online event that we're holding in conjunction with ZEISS:
This two-day complimentary program offers live sessions and an interactive product showcase—all within a virtual exhibit hall—designed to provide you with the latest technology innovations and clinical solutions for your practice.